EDIT - Rega Tumbas Perusahaan editasmedicine.com

Logo grafis Editas Corp (EDIT)

Editas Medicine, Inc. (EDIT) develops CRISPR systems where massive R&D expenditures are offset by future patent monopolies and minimal drug production costs. The price trend, which currently stands at 269.66, highlights a strategy of outsourcing testing and logistics to third-party contractors. Business prospects rely on the intensive preparation of data for sickle cell anemia therapy utilizing Cas12a technology.

Editas Corp - Nilai Perusahaan EDIT (periode 23.11.2025 - 31.10.2026)

Editas Medicine, Inc. (EDIT) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Kurs saham Editas Medicine Inc|EDIT - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Kapitalisasi pasar Editas Medicine|EDIT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data ekuitas miturut neraca:
Rega Buku Saham Editas Medicine|EDIT - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku editasmedicine.com|EDIT - Aset Agregat Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Utang marang Ekuitas Editas Medicine, Inc.|EDIT - Utang jangka dawa marang modal|Utang jangka cendhak marang modal editasmedicine.com|EDIT - Gunggung utang perusahaan|Utang-utang marang nilai buku Editas Medicine|EDIT - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Editas Medicine|Koefisien jangkoan perantara editasmedicine.com
- rincian asil keuangan lan kelipatan valuasi:
EDIT - Penghasilan resik
Ringkesan analitik perusahaan:Editas Medicine, Inc.
Barang unggulan Editas Medicine, Inc.

Ownership of fundamental CRISPR patents provides Editas Medicine, Inc. (EDIT) with a long-term royalty stream, transforming scientific capital into a sustainable financial asset. Analyzing the company's total capital level at 269.66 via the sum of market capitalization and net debt allows for the determination of the real business buyout value, eliminating liquidity distortions and confirming the asset's fundamental stability in a full acquisition.

Karo sapa Editas Medicine, Inc. saingan

TEM: Nilai Bisnis|Qiagen Group - Nilai Perusahaan|Rega Tumbas Perusahaan Isis Pharmaceuticals IONS|RGEN (Repligen Corporation) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|RNA: Total Nilai Bisnis|CRSP (CRISPR Therapeutics) - Nilai Perusahaan|Nilai Bisnis WGS (GeneDx Holdings)|Nilai Total Perusahaan Ultragenyx Pharma (RARE)|Beam Tx - Nilai Bisnis|Nilai Perusahaan SRPT (Sarepta Therapeutics, Inc.)|Nilai Perusahaan twistbioscience.com TWST|10x Genomics - Nilai Perusahaan|Total Nilai Perusahaan Intellia Therapeutics Inc|STOK: Nilai Perusahaan|Nilai Bisnis BLFS|WVE (Wave Life Sciences) - Nilai Perusahaan|mazetx.com (MAZE) - Rega Tumbas Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh SION (Sionna Therapeutics)|Total Nilai Bisnis PRME|Nilai Perusahaan TSHA (Taysha)|Nilai Perusahaan uniQure Pharma QURE|MGTX - Nilai Total Perusahaan|Rega Tumbas Perusahaan regenxbio.com RGNX|SLDB (Solid Biosciences) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Ocugen Inc - Nilai Dipunlarasaken Utang lan Kas|Nilai Total Perusahaan Pacific Biosciences of California|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Benitec Corp (BNTC)|Nilai Perusahaan DSGN|RCKT - Total Nilai Perusahaan|Nilai Perusahaan FDMT (4D Molecular Therapeutics, Inc.)|LXEO: Nilai Bisnis|Korro Bio, Inc - Nilai Perusahaan|Rega Tumbas Perusahaan Silence Therapeutics Corp SLN|PRQR: Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Codexis|SGMO (Sangamo Therapeutics, Inc.) - Nilai Perusahaan|Nautilus Biotechnology Inc (NAUT) - Rega Tumbas Perusahaan|Nilai Total Perusahaan Metagenomi, Inc (MGX)|precisionbiosciences.com - Nilai Bisnis|Nilai Perusahaan GBIO (Generation Bio)|boundlessbio.com (BOLD) - Total Nilai Perusahaan|XCUR: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas IMNN (Imunon, Inc.)|PHIO: Nilai Perusahaan|MBIO - Rega Tumbas Perusahaan|Nilai Total Perusahaan TransCode Therapeutics Inc.|Nilai Bisnis BNGO (Bionano)|Nilai Perusahaan APDN|Rega Nyata Tumbas Perusahaan Kanthi Wutuh bluebird bio Inc. BLUE|ImmunoPrecise Antibodies Ltd. - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Rega Tumbas Perusahaan Omega Therapeutics Corp (OMGA)|Singular Genomics Systems - Nilai Perusahaan|Total Nilai Perusahaan regulusrx.com|SYRS: Nilai Perusahaan|Nilai Bisnis TBIO|TCON (TRACON) - Nilai Perusahaan|Unity Biotechnology, Inc (UBX) - Rega Tumbas Perusahaan